A hidden weakness in deadly cancers could lead to powerful new treatments
UCLA researchers have identified that certain aggressive cancers lacking the RB gene are highly dependent on the E2F3 protein for survival. Blocking this protein could offer a new therapeutic strategy for treating difficult-to-cure tumors in the lung, prostate, and ovary.
Why it matters
This discovery of 'synthetic lethality' provides a potential breakthrough for treating cancers that have remained resistant to conventional therapies for decades.
Researchers at UCLA have identified a hidden weakness in some of the most aggressive and difficult-to-treat cancers, raising hopes for a new way to attack tumors that have resisted treatment for decades.
The article reports on medical research findings in a neutral, objective manner.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in